FDA Inspection 1027092 — Roche Molecular Systems, Inc.
The FDA completed an inspection of Roche Molecular Systems, Inc. on July 24, 2017 in Branchburg, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 24, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Branchburg, NJ (United States)